EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

The gut-heart axis in heart failure: a systematic review and meta-analysis of gut microbiota and metabolites

Fayez Yassine, Alia Albush, Aya Hanna, Hassan Abbas, Melhem Bilen

npj Biofilms and Microbiomes · 16.07.2026 · 12 (1)

DOI: 10.1038/s41522-026-01034-3 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift npj Biofilms and Microbiomes, online erschienen am 16.07.2026. Verfasst von Fayez Yassine und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. Hauptthemen laut MEDLINE: Heart Failure, Gastrointestinal Microbiome, Bacteria. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Faculty of Medicine, American University of Beirut.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure remains a major global health challenge. Emerging evidence highlights the gut microbiome's role in its pathogenesis and progression. This systematic review analyzed 32 studies involving 5825 patients to evaluate gut microbiota alterations and microbial metabolites in heart failure. Findings on alpha diversity were inconsistent, but beta diversity showed more agreement. A common pattern included depletion of short-chain fatty acid (SCFA)-producing bacteria and enrichment of pathogenic taxa such as Escherichia and Shigella. Heart failure patients also exhibited elevated levels of harmful metabolites like trimethylamine-N-oxide (TMAO) and phenylacetylglutamine. The dysbiotic profile was marked by increased Proteobacteria and decreased Firmicutes, linked to reduced cardioprotective metabolite production and heightened inflammation. These shifts may worsen heart failure prognosis and contribute to systemic inflammation. The results support the potential of microbiome-targeted therapies, such as probiotics, as adjunctive strategies in heart failure management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureGastrointestinal MicrobiomeBacteriaHumansDysbiosisMethylaminesFatty Acids, Volatile

Substanzen

MethylaminestrimethyloxamineFatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
  • Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. mb228@aub.edu.lb.

Förderung

  • Faculty of Medicine, American University of Beirut

Zitieren

APA

Yassine, F., Albush, A., Hanna, A., Abbas, H., & Bilen, M. (2026). The gut-heart axis in heart failure: a systematic review and meta-analysis of gut microbiota and metabolites. npj Biofilms and Microbiomes, 12(1). https://doi.org/10.1038/s41522-026-01034-3

Vancouver

Yassine F, Albush A, Hanna A, Abbas H, Bilen M. The gut-heart axis in heart failure: a systematic review and meta-analysis of gut microbiota and metabolites. npj Biofilms and Microbiomes. 2026;12(1). doi:10.1038/s41522-026-01034-3

BibTeX
@article{Yassine2026,
  author = {Yassine, Fayez and Albush, Alia and Hanna, Aya and Abbas, Hassan and Bilen, Melhem},
  title = {The gut-heart axis in heart failure: a systematic review and meta-analysis of gut microbiota and metabolites},
  journal = {npj Biofilms and Microbiomes},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1038/s41522-026-01034-3}
}
Kostenlos starten →